Glow
Research blend combining GHK-Cu, BPC-157, and TB-500, studied for synergistic effects on skin, tissue repair, and recovery.
Research Areas
Scientific Background
Glow is a research blend combining GHK-Cu (copper tripeptide, studied for collagen and skin remodeling), BPC-157 (a gastric-derived peptide studied for tissue repair), and TB-500 (a thymosin beta-4 fragment studied for cell migration and angiogenesis). The blend is investigated for potential synergistic effects across skin and connective tissue research.
Purity & Provenance
Why quality matters for research validity
Glow is a research blend (GHK-Cu + BPC-157 + TB-500). Each peptide component should be verified ≥98% purity by HPLC.
Areas of Investigation
Laboratory Information
Technical specifications for research settings
This compound is intended for qualified scientific research only. Not for human or veterinary use. Not for diagnostic or therapeutic applications. Researchers must comply with all applicable regulations in their jurisdiction.
Store lyophilized at -20°C. Protect from light.
Lyophilized powder (blend)
>98% by HPLC (each component)
Soluble in bacteriostatic water
For in vitro regenerative research applications.
Deepen Your Research
Published literature and clinical trial registries
Published Literature
Each component has an independent research literature: Pickart & Margolina reviewed GHK-Cu in tissue remodeling; Sikiric et al. studied BPC-157 in tissue repair; Goldstein et al. examined thymosin beta-4 (TB-500) in cell migration and angiogenesis. The combination is studied for complementary regenerative pathways.
Regulatory Classification
Glow is a research blend not approved by the FDA. None of its components are FDA-approved. Available for qualified research purposes only.
Important Research Notice
This information is compiled from scientific literature for educational purposes only. This website does not sell, distribute, or recommend any compounds for human use. All compounds discussed are for qualified research purposes only.